The New Opportunity in Pharmaceutical Outsourcing: Portfolio Maintenance
March 9th 2022For decades, the power and potential of outsourcing has been viewed as a way for pharmaceutical companies to gain access to specialized domain expertise across geographic regions and achieve cost savings amidst a highly complex and diverse regulatory environment. In the face of dwindling drug pipelines, complex regulations and block-busters crossing their patent exclusivity, mature products offer a revenue stream for companies to sustain their bottom lines in a hyper-competitive global market.
Tech Talks: Cell & Gene Therapy Series
February 2nd 2022Cell and gene therapies continue to expand rapidly, with an anticipated exponential growth over the next five years. This rapid growth has left an urgent need for industry scientists to gather and share lessons learned concerning bioanalytical, biomarker and regulatory strategies. This series provides insight from PPD Laboratories’ experts into a variety of cell and gene therapy (CGT) modalities in the bioanalytical community, with detailed discussions that leverage their experience with technologies and modalities within this CGT sphere.
Ultra-Sensitive LC-MRM Analysis for Trastuzumab emtansine Quantification in Rat Plasma
December 3rd 2021Eshani Nandita, Ph.D., Global Biopharma Quant Technical Marketing Lead at Sciex, presented the company’s poster Ultra-Sensitive LC-MRM Analysis for Trastuzumab emtansine Quantification in Rat Plasma at AAPS 2021 PharmSci 360.
Impact of Opacifier Type in a Film Coating Formulation on Photostability of Tablet Ingredients
November 15th 2021Manish Ghimire, Ph.D., Product Development Manager at Colorcon, Inc., presented the company’s poster Impact of Opacifier Type in a Film Coating Formulation on Photostability of Tablet Ingredients at AAPS 2021 PharmSci 360.